I did find it interesting that CF-33 was being trialled in combination with Merck's Keytruda.
Merck previously purchased and subsequently shelved Cavatak which was PH's drug from the VLA days. Merck did make the decision to buy Cavatak and I'm assuming they did their own DD but I did wonder if this would have a negative impact on any future deals related to P.H.
But either way I'm sure purchasing a $400m dust collector didn't go down too well.
IMU Price at posting:
2.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)